(Q46965417)

English

Antihypertensive efficacy of the oral direct renin inhibitor aliskiren as add-on therapy in patients not responding to amlodipine monotherapy

scientific article published in October 2007

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/17917501

Antihypertensive efficacy of the oral direct renin inhibitor aliskiren as add-on therapy in patients not responding to amlodipine monotherapy (English)

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/17917501

0 references

author name string

Waymon Drummond

1

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/17917501

Mark A Munger

2

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/17917501

Mohammed Rafique Essop

3

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/17917501

Mojdeh Maboudian

4

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/17917501

Mahmudul Khan

5

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/17917501

Deborah L Keefe

6

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/17917501

publication date

1 October 2007

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/17917501

Journal of Clinical Hypertension

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/17917501

9

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/17917501

10

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/17917501

742-750

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/17917501

Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2007.06614.X

21 January 2018

2003 European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2007.06614.X

21 January 2018

Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2007.06614.X

21 January 2018

Outpatient hypertension treatment, treatment intensification, and control in Western Europe and the United States.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2007.06614.X

21 January 2018

British Hypertension Society guidelines for hypertension management 2004 (BHS-IV): summary

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2007.06614.X

21 January 2018

Effect of the renin-angiotensin system or calcium channel blockade on the circadian variation of heart rate variability, blood pressure and circulating catecholamines in hypertensive patients

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2007.06614.X

21 January 2018

Effects of selective angiotensin II receptor blockade on sympathetic nerve activity in primary hypertensive subjects

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2007.06614.X

21 January 2018

Matching the right drug to the right patient in essential hypertension

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2007.06614.X

21 January 2018

Amlodipine increases nitric oxide production in exhaled air during exercise in patients with essential hypertension

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2007.06614.X

21 January 2018

Comparative effect of ace inhibition and angiotensin II type 1 receptor antagonism on bioavailability of nitric oxide in patients with coronary artery disease: role of superoxide dismutase

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2007.06614.X

21 January 2018

Restoration of nitric oxide availability after calcium antagonist treatment in essential hypertension

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2007.06614.X

21 January 2018

Effect of AT1 receptor blockade on endothelial function in essential hypertension

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2007.06614.X

21 January 2018

Combination of ACE inhibitors and calcium antagonists: a logical approach

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2007.06614.X

21 January 2018

Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (A

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2007.06614.X

21 January 2018

Initial angiotensin-converting enzyme inhibitor/calcium channel blocker combination therapy achieves superior blood pressure control compared with calcium channel blocker monotherapy in patients with stage 2 hypertension

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2007.06614.X

21 January 2018

Comparison of the antihypertensive effects of the fixed dose combination enalapril 10 mg/nitrendipine 20 mg vs losartan 50 mg/hydrochlorothiazide 12.5 mg, assessed by 24-h ambulatory blood pressure monitoring, in essential hypertensive patients

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2007.06614.X

21 January 2018

Angiotensin II suppression in humans by the orally active renin inhibitor Aliskiren (SPP100): comparison with enalapril

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2007.06614.X

21 January 2018

Structure-based design of aliskiren, a novel orally effective renin inhibitor

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2007.06614.X

21 January 2018

Aliskiren, a novel orally effective renin inhibitor, provides dose-dependent antihypertensive efficacy and placebo-like tolerability in hypertensive patients

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2007.06614.X

21 January 2018

Blood pressure lowering in essential hypertension with an oral renin inhibitor, aliskiren

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2007.06614.X

21 January 2018

Renin inhibition with aliskiren provides additive antihypertensive efficacy when used in combination with hydrochlorothiazide.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2007.06614.X

21 January 2018

Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2007.06614.X

21 January 2018

Heterogeneous effect of calcium antagonists on leg oedema: a comparison of amlodipine versus lercanidipine in hypertensive patients

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2007.06614.X

21 January 2018

Identifiers

10.1111/J.1524-6175.2007.06614.X

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/17917501

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/17917501

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46965417&oldid=2140103887"